中紅醫療(300981.SZ):擬斥資665.085萬元-1330.00萬元回購股份
格隆匯2月27日丨中紅醫療(300981.SZ)公佈,自2024年1月12日起至2024年2月8日,中紅普林醫療用品股份有限公司(簡稱“公司”)股票收盤價已連續20個交易日低於15.1519元/股,根據公司《股票上市後三年內公司股價穩定預案》,達到觸發穩定股價措施的啟動條件。為履行穩定股價承諾、並基於對公司價值的判斷和未來發展的信心,綜合考慮公司的經營情況及財務狀況等因素,計劃使用自有資金以集中競價交易方式回購公司股份,用於維護公司價值及股東權益所必需。
本次回購股份的種類為公司已發行的人民幣普通股(A股),本次回購的股份用於維護公司價值及股東權益所必需。公司回購股票資金總額不低於人民幣6,650,850元(含本數),不高於人民幣13,300,003元(含本數),回購金額上限不高於最近一期經審計淨利潤的20%且上限不高於下限2倍,回購價格不超過人民幣15.15元/股(含本數)。按照回購價格上限和回購金額下限測算,預計可回購股份數量為439,000股,約佔公司總股本剔除回購專用賬户股份後的0.113%;按照回購價格上限和回購金額上限測算,預計可回購股份數量為877,888股,約佔公司總股本剔除回購專用賬户股份後的0.225%。具體回購股份的金額及數量以回購期滿時實際回購的股份數量為準。回購股份的實施期限自公司2024年第一次臨時股東大會審議通過本次回購方案之日起三個月內。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.